ShuYu Civilian Pharmacy Corp. Ltd.
ShuYu Civilian Pharmacy Corp., Ltd. engages in the pharmaceutical retail chain business in China. The company is also involved in the pharmaceutical wholesale business. ShuYu Civilian Pharmacy Corp., Ltd. was founded in 1999 and is based in Jinan, China.
ShuYu Civilian Pharmacy Corp. Ltd. (301017) - Net Assets
Latest net assets as of June 2025: CN¥2.19 Billion CNY
Based on the latest financial reports, ShuYu Civilian Pharmacy Corp. Ltd. (301017) has net assets worth CN¥2.19 Billion CNY as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥9.84 Billion) and total liabilities (CN¥7.65 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥2.19 Billion |
| % of Total Assets | 22.27% |
| Annual Growth Rate | 9.89% |
| 5-Year Change | 38.88% |
| 10-Year Change | N/A |
| Growth Volatility | 12.37 |
ShuYu Civilian Pharmacy Corp. Ltd. - Net Assets Trend (2019–2024)
This chart illustrates how ShuYu Civilian Pharmacy Corp. Ltd.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for ShuYu Civilian Pharmacy Corp. Ltd. (2019–2024)
The table below shows the annual net assets of ShuYu Civilian Pharmacy Corp. Ltd. from 2019 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥2.13 Billion | -10.19% |
| 2023-12-31 | CN¥2.37 Billion | +4.37% |
| 2022-12-31 | CN¥2.27 Billion | +18.44% |
| 2021-12-31 | CN¥1.91 Billion | +25.09% |
| 2020-12-31 | CN¥1.53 Billion | +15.39% |
| 2019-12-31 | CN¥1.33 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to ShuYu Civilian Pharmacy Corp. Ltd.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 94.3% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥631.75 Million | 30.96% |
| Other Components | CN¥1.41 Billion | 69.04% |
| Total Equity | CN¥2.04 Billion | 100.00% |
ShuYu Civilian Pharmacy Corp. Ltd. Competitors by Market Cap
The table below lists competitors of ShuYu Civilian Pharmacy Corp. Ltd. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
SOUTHERN STS BANCSH. DL 5
F:6U2
|
$188.59 Million |
|
FIELMANN AG (ADR/1/5)O.N.
F:FIE1
|
$188.61 Million |
|
Launch Two Acquisition Corp. Class A Ordinary Shares
NASDAQ:LPBB
|
$188.65 Million |
|
Padini Holdings Bhd
KLSE:7052
|
$188.83 Million |
|
Sichuan Dowell Science and Technology Inc
SHE:300535
|
$188.52 Million |
|
Nanjing Res In of Surveying Mapping
SHE:300826
|
$188.50 Million |
|
Nantex Industry Co Ltd
TW:2108
|
$188.45 Million |
|
Mingxin Automotive Leather Co. Ltd.
SHG:605068
|
$188.41 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in ShuYu Civilian Pharmacy Corp. Ltd.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 2,292,063,022 to 2,040,366,110, a change of -251,696,911 (-11.0%).
- Net loss of 188,810,298 reduced equity.
- Dividend payments of 102,995,221 reduced retained earnings.
- Other factors increased equity by 40,108,608.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥-188.81 Million | -9.25% |
| Dividends Paid | CN¥103.00 Million | -5.05% |
| Other Changes | CN¥40.11 Million | +1.97% |
| Total Change | CN¥- | -10.98% |
Book Value vs Market Value Analysis
This analysis compares ShuYu Civilian Pharmacy Corp. Ltd.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.84x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 3.96x to 2.84x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | CN¥3.61 | CN¥14.31 | x |
| 2020-12-31 | CN¥4.17 | CN¥14.31 | x |
| 2021-12-31 | CN¥4.66 | CN¥14.31 | x |
| 2022-12-31 | CN¥5.50 | CN¥14.31 | x |
| 2023-12-31 | CN¥5.65 | CN¥14.31 | x |
| 2024-12-31 | CN¥5.03 | CN¥14.31 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently ShuYu Civilian Pharmacy Corp. Ltd. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -9.25%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -1.97%
- • Asset Turnover: 1.03x
- • Equity Multiplier: 4.54x
- Recent ROE (-9.25%) is below the historical average (5.93%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | 8.44% | 3.21% | 1.42x | 1.85x | CN¥-20.63 Million |
| 2020 | 14.23% | 4.66% | 1.33x | 2.29x | CN¥64.37 Million |
| 2021 | 6.08% | 2.16% | 1.06x | 2.65x | CN¥-74.03 Million |
| 2022 | 10.28% | 2.93% | 0.99x | 3.52x | CN¥6.30 Million |
| 2023 | 5.81% | 1.45% | 0.98x | 4.07x | CN¥-96.15 Million |
| 2024 | -9.25% | -1.97% | 1.03x | 4.54x | CN¥-392.85 Million |
Industry Comparison
This section compares ShuYu Civilian Pharmacy Corp. Ltd.'s net assets metrics with peer companies in the Pharmaceutical Retailers industry.
Industry Context
- Industry: Pharmaceutical Retailers
- Average net assets among peers: $2,027,547,861
- Average return on equity (ROE) among peers: 9.03%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| ShuYu Civilian Pharmacy Corp. Ltd. (301017) | CN¥2.19 Billion | 8.44% | 3.49x | $188.58 Million |
| Cachet Pharmaceutical Co Ltd (002462) | $4.92 Billion | 13.40% | 1.65x | $437.62 Million |
| Yunnan Hongxiang Yixintang (002727) | $497.43 Million | 20.70% | 1.22x | $545.21 Million |
| Luyan Pharma Co Ltd (002788) | $746.00 Million | 15.21% | 3.60x | $450.11 Million |
| Ji Yao Holding Group Co Ltd (300108) | $-366.31 Million | 0.00% | 0.00x | $18.23 Million |
| Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co. Ltd. (300937) | $856.04 Million | 6.95% | 0.97x | $170.91 Million |
| Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126) | $1.78 Billion | 1.93% | 1.96x | $174.48 Million |
| Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A (301408) | $1.98 Billion | 5.80% | 1.33x | $323.73 Million |
| Shanghai No1 Pharmacy Co Ltd (600833) | $736.00 Million | 6.25% | 0.61x | $180.65 Million |
| Laobaixing Pharmacy (603883) | $7.10 Billion | 11.06% | 2.01x | $739.96 Million |